Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline?

被引:49
作者
Alagiakrishnan, K
McCracken, P
Feldman, H
机构
[1] Univ Alberta, Div Geriatr Med, Edmonton, AB, Canada
[2] Univ British Columbia, Div Neurol, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1136/pgmj.2005.035030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dementia is a progressive disorder that typically worsens with time and from which recovery is unlikely. The incidence of dementia increases exponentially with ageing and is an important public health challenge. There is now growing evidence for the role of vascular factors in Alzheimer's disease, mixed dementia (Alzheimer's disease with cerebrovascular disease), and of course vascular dementia. With the rising prevalence of vascular disease, there are increasing numbers of people who are identified to be at risk of cognitive impairment. By changing modifiable vascular risk factors, there is emerging evidence that it may be possible to prevent or delay the expression and progression of dementia.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 54 条
[1]  
[Anonymous], 1991, JAMA, V265, P3255
[2]   Survival following a diagnosis of Alzheimer disease [J].
Brookmeyer, R ;
Corrada, MM ;
Curriero, FC ;
Kawas, C .
ARCHIVES OF NEUROLOGY, 2002, 59 (11) :1764-1767
[3]   Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset [J].
Brookmeyer, R ;
Gray, S ;
Kawas, C .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) :1337-1342
[4]  
Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176
[5]   Statins in the prevention and treatment of Alzheimer disease [J].
Crisby, M ;
Carlson, LA ;
Winblad, B .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (03) :131-136
[6]   Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo [J].
Fassbender, K ;
Simons, M ;
Bergmann, C ;
Stroick, M ;
Lütjohann, D ;
Keller, P ;
Runz, H ;
Kühl, S ;
Bertsch, T ;
von Bergmannn, K ;
Hennerici, M ;
Beyreuther, K ;
Hartmann, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (10) :5856-5861
[7]   Oxidative stress in brain aging - Implications for therapeutics of neurodegenerative diseases [J].
Floyd, RA ;
Hensley, K .
NEUROBIOLOGY OF AGING, 2002, 23 (05) :795-807
[8]   Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial [J].
Forette, F ;
Seux, ML ;
Staessen, JA ;
Thijs, L ;
Birkenhäger, WH ;
Babarskiene, MR ;
Babeanu, S ;
Bossini, A ;
Gil-Extremera, B ;
Girerd, X ;
Laks, T ;
Lilov, E ;
Moisseyev, V ;
Tuomilehto, J ;
Vanhanen, H ;
Webster, J ;
Yodfat, Y ;
Fagard, R .
LANCET, 1998, 352 (9137) :1347-1351
[9]   The prevention of dementia with antihypertensive treatment [J].
Forette, F ;
Seux, ML ;
Staessen, JA ;
Thijs, L ;
Babarskiene, MR ;
Babeanu, S ;
Bossini, A ;
Fagard, R ;
Gil-Extremera, B ;
Laks, T ;
Kobalava, Z ;
Sarti, C ;
Tuomilehto, J ;
Vanhanen, H ;
Webster, J ;
Yodfat, Y ;
Birkenhäger, WH .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (18) :2046-2052
[10]   An active and socially integrated lifestyle in late life might protect against dementia [J].
Fratiglioni, L ;
Paillard-Borg, S ;
Winblad, B .
LANCET NEUROLOGY, 2004, 3 (06) :343-353